Length of hospital stay (days) Including the index admission for oesophagectomy (the hospital admission during which the oesophagectomy is performed) and any surgical complication‐related readmissions · patients with oesophageal cancer
1 finding from 1 review
Leukocytosis resolution time (days) · patients with septic abortion
1 finding from 1 review
Fever clearance time · patients with septic abortion
1 finding from 1 review
Neonatal mortality · very preterm infants at risk of intraventricular hemorrhage
It is very uncertain whether antithrombin changes neonatal mortality (all‐cause, < 28 days of age) compared with placebo (very low certainty).
1 finding from 1 review
Asthma symptoms · children with acute asthma
Children: higher dose/longer course showed no clear difference in asthma symptoms Symptom free by 7 days compared with lower dose/shorter course (moderate certainty).
1 finding from 1 review
Asthma symptoms Complete resolution by day 28 · Adults with acute asthma
Adults: higher dose/longer course showed no clear difference in asthma symptoms Complete resolution by day 28 compared with lower dose/shorter course (low certainty).
1 finding from 1 review
Asthma symptoms Returned to normal activities within 3 days · Adults with acute asthma
Adults: prednisolone showed no clear difference in asthma symptoms Returned to normal activities within 3 days compared with dexamethasone (low certainty).
1 finding from 1 review
Intervention not reported
30‐day mortality4 · individuals with atrial fibrillation who are undergoing cardiac surgery
The intervention showed no clear difference in 30‐day mortality4 (low certainty).
1 finding from 1 review
Numbers of working days or days lost related to influenza illness · Adults and elderly
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Initiation of oral feeding (days) · patients with the management of transient tachypnea of the newborn
1 finding from 1 review
Intervention not reported
Cognition (at 90 days): t‐MMSE score1 · adults with cognitive impairment/dementia and cognitively intact populations
1 finding from 1 review
Participants with ≥ 1 adverse event following a single dose, and after 3 to 5 days · adults with moderate or severe acute postoperative pain
1 finding from 1 review
Participants with a serious adverse event following a single dose, and after 3 to 5 days · adults with moderate or severe acute postoperative pain
1 finding from 1 review
Death of a baby (stillbirth or neonatal death) report of perinatal death · women with breech presentation before term
External cephalic version (ECV) commenced before term showed no clear difference in perinatal mortality (Stillbirth or neonatal mortality < 7 days) compared with ECV at term (low certainty).
1 finding from 1 review
Chronic lung disease · preterm infants with severe pulmonary dysfunction
Rescue high‐frequency jet ventilation showed no clear difference in chronic lung disease at 28 days of birth (CLD 28 days) compared with conventional ventilation (low certainty).
1 finding from 1 review
Cough · people with acute cough or a clinical diagnosis of acute bronchitis
4 findings from 1 review
no estimate extracted
2 studies · 96 participants
Moderate
no estimate extracted
2 studies · 95 participants
Moderate
RR 0.89 [0.47, 1.68]
1 study · 59 participants
Moderate
Show 1 more finding
Adults: night cough after seven days diary · people with acute cough or a clinical diagnosis of acute bronchitis
Beta‐2 agonists showed no clear difference in adults: night cough after seven days diary compared with placebo (moderate certainty).
1 finding from 1 review
Change in total calories (Kcal/day): at 12 months · children with chronic disease
1 finding from 1 review
Change in total protein intake (g/day) at 3 months · children with chronic disease
1 finding from 1 review
Intervention not reported
Postoperative mortality (within 30 days from surgery) · patients with resectable disease
1 finding from 1 review